Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3326 Target Snapshot

Beta-lactamase L1 · SINGLE PROTEIN · Stenotrophomonas maltophilia

163Compounds
16Assays
0Approved Drugs
94.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P52700. Use UniProt P52700 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P52700 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-lactamase L1 as ChEMBL target CHEMBL3326, mapped to UniProt P52700. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-lactamase L1
SINGLE PROTEIN · Stenotrophomonas maltophilia
As of 2026-09-14
ChEMBL target ID
CHEMBL3326
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P52700
Metallo-beta-lactamase L1 type 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-lactamase L1 is the right protein anchor across sources, using UniProt P52700 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMetallo-beta-lactamase L1 type 3
UniProt AccessionP52700
Component TypeProtein
Sequence Length290 aa

Metallo-beta-lactamase L1 type 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-lactamase L1, mapped to UniProt P52700. ChEMBL maps the protein component as Metallo-beta-lactamase L1 type 3. Sequence length is 290 aa.

Mapped IDP52700
Review nameBeta-lactamase L1
OrganismStenotrophomonas maltophilia
Assay Mix

Activity Type Distribution

IC5028.0
KI66.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL215590 8.68 Ki 2.1 Preclinical
CHEMBL217877 7.92 Ki 12.0 Preclinical
CHEMBL386173 7.92 Ki 12.0 Preclinical
CHEMBL3586478 7.75 IC50 18.0 Preclinical
CHEMBL385145 7.58 Ki 26.0 Preclinical
CHEMBL3586477 7.16 IC50 69.0 Preclinical
CHEMBL25766 7.0 IC50 100.0 Preclinical
CHEMBL3586478 6.96 Ki 110.0 Preclinical
CHEMBL385485 6.85 Ki 140.0 Preclinical
CHEMBL385075 6.82 Ki 150.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
7
5.5
20
6.0
22
6.5
2
7.0
4
7.5
1
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

16
Total Assays
58
Tested Compounds
1
Assay Types
Binding — 16 assays, 58 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 48 6.0
assay format 6 10 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine